The Spindle Checkpoint as a Target for Cancer
The Spindle Checkpoint as a Target for Cancer
批准号:
6334126
负责人:
GARY J. GORBSKY
金额:
$13.76万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-03-01 至 2003-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (provided by applicant)
The spindle checkpoint is a signaling pathway that normally promotes the
proper segregation of chromosomes in M phase. If in mitosis the chromosomes
are not properly aligned on the mitotic spindle, the spindle checkpoint halts
cell cycle progression prior to the metaphase-to-anaphase transition. This
delay allows more time for chromosomes to attach the mtitotic spindle
microtubules and move to their proper positions at the midplane of the cell.
Individual cells can be artificially forced to override the spindle checkpoint
by the injection of antibodies to proteins of the spindle checkpoint or by
transfection of cDNA's encoding mutant, dominant-negative spindle checkpoint
proteins. These interventions induce massive imbalances in chromosome
segregation that can be directly lethal or cause apoptosis. Tumor cells often
exhibit defective checkpoint responses compared to normal somatic cells. The
relative weakness of tumor cells to induce cell cycle checkpoints in response
to damage may be one mechanism by which anti-cancer therapies show some
selectivity for tumors. Drugs that specifically target cell cycle checkpoints
may be useful in further sensitizing tumor cell population to therapy. There
are currently no cell permeable drugs that can inactivate the spindle
checkpoint. The project proposed here is to develop and institute a high
throughput screen for drugs that can penetrate cell membranes and inactivate
the spindle checkpoint. Several of the protein components of the spindle
checkpoint pathway have no other functions. Thus it is reasonable that
specific small molecule inhibitors of this pathway can be found. Once
effective drugs have been identified, the specific proteins of the spindle
checkpoint pathway that are targeted will be determined. It is anticipated
that these drugs will be clinically useful for anti-cancer therapy,
particularly when used in combination with chemotherapeutic anti-microtubule
drugs such as the vinca alkaloids and the taxanes which are themselves potent
inducers of the spindle checkpoint.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Imaging Core
-
批准号:10629616
-
项目类别:
-
资助金额:$25.84万
-
财政年份:2023
-
负责人:GARY J. GORBSKY
-
依托单位:
Understanding Cell Division
-
批准号:10439611
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2018
-
负责人:GARY J. GORBSKY
-
依托单位:
Understanding Cell Division
-
批准号:10188558
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2018
-
负责人:GARY J. GORBSKY
-
依托单位:
Understanding Cell Division
-
批准号:10387165
-
项目类别:
-
资助金额:$1.12万
-
财政年份:2018
-
负责人:GARY J. GORBSKY
-
依托单位:
The role of cohesion fatigue in chromosome instability
-
批准号:8758530
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2014
-
负责人:GARY J. GORBSKY
-
依托单位:
The role of cohesion fatigue in chromosome instability
-
批准号:9323451
-
项目类别:
-
资助金额:$32.59万
-
财政年份:2014
-
负责人:GARY J. GORBSKY
-
依托单位:
The role of cohesion fatigue in chromosome instability
-
批准号:8921235
-
项目类别:
-
资助金额:$32.59万
-
财政年份:2014
-
负责人:GARY J. GORBSKY
-
依托单位:
The role of cohesion fatigue in chromosome instability
-
批准号:9266556
-
项目类别:
-
资助金额:$8.63万
-
财政年份:2014
-
负责人:GARY J. GORBSKY
-
依托单位:
Imaging Core
-
批准号:10225572
-
项目类别:
-
资助金额:$20.72万
-
财政年份:2013
-
负责人:GARY J. GORBSKY
-
依托单位:
Imaging Core
-
批准号:10474295
-
项目类别:
-
资助金额:$25.1万
-
财政年份:2013
-
负责人:GARY J. GORBSKY
-
依托单位:
Chromosome Movement in Prometaphase
-
批准号:7999990
-
项目类别:
-
资助金额:$9.17万
-
财政年份:2010
-
负责人:GARY J. GORBSKY
-
依托单位:
A CELL DYNAMICS MICROSCOPE FOR LIVE CELL FLUORESCENCE: CELL BIOLOGY
-
批准号:6973507
-
项目类别:
-
资助金额:$41.36万
-
财政年份:2004
-
负责人:GARY J. GORBSKY
-
依托单位:
A Cell Dynamics Microscope for Live Cell Fluorescence
-
批准号:6731542
-
项目类别:
-
资助金额:$41.36万
-
财政年份:2004
-
负责人:GARY J. GORBSKY
-
依托单位:
The Spindle Checkpoint as a Target for Cancer
-
批准号:6515074
-
项目类别:
-
资助金额:$14.55万
-
财政年份:2001
-
负责人:GARY J. GORBSKY
-
依托单位:
PROTEIN ABLATION MICROSCOPE
-
批准号:2486867
-
项目类别:
-
资助金额:$21.16万
-
财政年份:1998
-
负责人:GARY J. GORBSKY
-
依托单位:
CHROMOSOME MOVEMENT IN PROMETAPHASE
-
批准号:2188245
-
项目类别:
-
资助金额:$11.69万
-
财政年份:1994
-
负责人:GARY J. GORBSKY
-
依托单位:
Chromosome Movement in Prometaphase
-
批准号:6370589
-
项目类别:
-
资助金额:$29.2万
-
财政年份:1994
-
负责人:GARY J. GORBSKY
-
依托单位:
Chromosome Movement in Prometaphase
-
批准号:6984654
-
项目类别:
-
资助金额:$35.68万
-
财政年份:1994
-
负责人:GARY J. GORBSKY
-
依托单位:
Chromosome Movement in Prometaphase
-
批准号:7114832
-
项目类别:
-
资助金额:$35.2万
-
财政年份:1994
-
负责人:GARY J. GORBSKY
-
依托单位:
Chromosome Movement in Prometaphase
-
批准号:7730735
-
项目类别:
-
资助金额:$40.75万
-
财政年份:1994
-
负责人:GARY J. GORBSKY
-
依托单位:
海外基金